share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

SEC announcement ·  May 2 03:42
Summary by Futu AI
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 30, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Following the action, the updated number of shares held by Bourla was not provided. This transaction is part of the regular financial disclosures made by company executives, which are closely monitored by investors for insights into executive confidence and company performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.